nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—GABRA2—conduct disorder	0.901	1	CbGaD
Flunitrazepam—GABRA6—GABA A receptor activation—GABRA2—conduct disorder	0.00529	0.0585	CbGpPWpGaD
Flunitrazepam—GABRA4—GABA A receptor activation—GABRA2—conduct disorder	0.00522	0.0578	CbGpPWpGaD
Flunitrazepam—GABRA5—GABA A receptor activation—GABRA2—conduct disorder	0.00464	0.0514	CbGpPWpGaD
Flunitrazepam—GABRA3—GABA A receptor activation—GABRA2—conduct disorder	0.00455	0.0504	CbGpPWpGaD
Flunitrazepam—GABRA1—GABA A receptor activation—GABRA2—conduct disorder	0.00382	0.0423	CbGpPWpGaD
Flunitrazepam—GABRA6—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00324	0.0358	CbGpPWpGaD
Flunitrazepam—GABRA4—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.0032	0.0354	CbGpPWpGaD
Flunitrazepam—GABRA5—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00284	0.0314	CbGpPWpGaD
Flunitrazepam—GABRA3—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00279	0.0309	CbGpPWpGaD
Flunitrazepam—GABRA1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00234	0.0259	CbGpPWpGaD
Flunitrazepam—UGT1A3—Estrogen metabolism—COMT—conduct disorder	0.00224	0.0248	CbGpPWpGaD
Flunitrazepam—UGT2B7—Estrogen metabolism—COMT—conduct disorder	0.0019	0.0211	CbGpPWpGaD
Flunitrazepam—GABRA6—GABA receptor activation—GABRA2—conduct disorder	0.00172	0.019	CbGpPWpGaD
Flunitrazepam—GABRA4—GABA receptor activation—GABRA2—conduct disorder	0.0017	0.0188	CbGpPWpGaD
Flunitrazepam—UGT1A1—Estrogen metabolism—COMT—conduct disorder	0.00155	0.0171	CbGpPWpGaD
Flunitrazepam—GABRA5—GABA receptor activation—GABRA2—conduct disorder	0.00151	0.0167	CbGpPWpGaD
Flunitrazepam—GABRA3—GABA receptor activation—GABRA2—conduct disorder	0.00148	0.0164	CbGpPWpGaD
Flunitrazepam—GABRA1—GABA receptor activation—GABRA2—conduct disorder	0.00124	0.0137	CbGpPWpGaD
Flunitrazepam—GABRA6—Orphan transporters—GABRA2—conduct disorder	0.001	0.0111	CbGpPWpGaD
Flunitrazepam—GABRA4—Orphan transporters—GABRA2—conduct disorder	0.000989	0.0109	CbGpPWpGaD
Flunitrazepam—CYP1A2—Methylation—COMT—conduct disorder	0.000907	0.01	CbGpPWpGaD
Flunitrazepam—GABRA5—Orphan transporters—GABRA2—conduct disorder	0.000878	0.00973	CbGpPWpGaD
Flunitrazepam—GABRA3—Orphan transporters—GABRA2—conduct disorder	0.000863	0.00955	CbGpPWpGaD
Flunitrazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000789	0.00874	CbGpPWpGaD
Flunitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000779	0.00863	CbGpPWpGaD
Flunitrazepam—Clotiazepam—GABRA2—conduct disorder	0.000743	0.0856	CrCbGaD
Flunitrazepam—GABRA1—Orphan transporters—GABRA2—conduct disorder	0.000723	0.00801	CbGpPWpGaD
Flunitrazepam—GABRA6—Ion channel transport—GABRA2—conduct disorder	0.000702	0.00778	CbGpPWpGaD
Flunitrazepam—Alprazolam—GABRA2—conduct disorder	0.000702	0.0809	CrCbGaD
Flunitrazepam—GABRA4—Ion channel transport—GABRA2—conduct disorder	0.000694	0.00768	CbGpPWpGaD
Flunitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000693	0.00767	CbGpPWpGaD
Flunitrazepam—Cinolazepam—GABRA2—conduct disorder	0.000684	0.0788	CrCbGaD
Flunitrazepam—Quazepam—GABRA2—conduct disorder	0.00068	0.0784	CrCbGaD
Flunitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00068	0.00753	CbGpPWpGaD
Flunitrazepam—UGT1A3—Phase II conjugation—COMT—conduct disorder	0.000629	0.00697	CbGpPWpGaD
Flunitrazepam—GABRA5—Ion channel transport—GABRA2—conduct disorder	0.000616	0.00682	CbGpPWpGaD
Flunitrazepam—GABRA3—Ion channel transport—GABRA2—conduct disorder	0.000605	0.0067	CbGpPWpGaD
Flunitrazepam—Estazolam—GABRA2—conduct disorder	0.000601	0.0693	CrCbGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000593	0.00657	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000586	0.00649	CbGpPWpGaD
Flunitrazepam—Halazepam—GABRA2—conduct disorder	0.000584	0.0673	CrCbGaD
Flunitrazepam—Nitrazepam—GABRA2—conduct disorder	0.00058	0.0668	CrCbGaD
Flunitrazepam—Adinazolam—GABRA2—conduct disorder	0.000572	0.0659	CrCbGaD
Flunitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00057	0.00631	CbGpPWpGaD
Flunitrazepam—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.000567	0.00628	CbGpPWpGaD
Flunitrazepam—Fludiazepam—GABRA2—conduct disorder	0.000566	0.0653	CrCbGaD
Flunitrazepam—UGT1A3—NRF2 pathway—SLC6A4—conduct disorder	0.000554	0.00613	CbGpPWpGaD
Flunitrazepam—Prazepam—GABRA2—conduct disorder	0.000553	0.0637	CrCbGaD
Flunitrazepam—UGT2B7—Phase II conjugation—COMT—conduct disorder	0.000535	0.00593	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000521	0.00577	CbGpPWpGaD
Flunitrazepam—Flurazepam—GABRA2—conduct disorder	0.000516	0.0594	CrCbGaD
Flunitrazepam—Triazolam—GABRA2—conduct disorder	0.000515	0.0594	CrCbGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000511	0.00566	CbGpPWpGaD
Flunitrazepam—GABRA1—Ion channel transport—GABRA2—conduct disorder	0.000507	0.00562	CbGpPWpGaD
Flunitrazepam—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.000493	0.00546	CbGpPWpGaD
Flunitrazepam—Temazepam—GABRA2—conduct disorder	0.000493	0.0568	CrCbGaD
Flunitrazepam—Midazolam—GABRA2—conduct disorder	0.000478	0.0551	CrCbGaD
Flunitrazepam—UGT2B7—NRF2 pathway—SLC6A4—conduct disorder	0.000471	0.00522	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—GABRA2—conduct disorder	0.000455	0.00504	CbGpPWpGaD
Flunitrazepam—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000453	0.00502	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—GABRA2—conduct disorder	0.000449	0.00497	CbGpPWpGaD
Flunitrazepam—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.000437	0.00484	CbGpPWpGaD
Flunitrazepam—UGT1A1—Phase II conjugation—COMT—conduct disorder	0.000435	0.00482	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000428	0.00474	CbGpPWpGaD
Flunitrazepam—Diazepam—GABRA2—conduct disorder	0.00041	0.0472	CrCbGaD
Flunitrazepam—GABRA5—Neuronal System—GABRA2—conduct disorder	0.000399	0.00442	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—GABRA2—conduct disorder	0.000392	0.00434	CbGpPWpGaD
Flunitrazepam—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.000384	0.00426	CbGpPWpGaD
Flunitrazepam—UGT1A1—NRF2 pathway—SLC6A4—conduct disorder	0.000383	0.00424	CbGpPWpGaD
Flunitrazepam—UGT1A3—Biological oxidations—COMT—conduct disorder	0.000368	0.00408	CbGpPWpGaD
Flunitrazepam—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000367	0.00406	CbGpPWpGaD
Flunitrazepam—UGT1A3—Biological oxidations—MAOA—conduct disorder	0.000366	0.00405	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metapathway biotransformation—COMT—conduct disorder	0.000363	0.00402	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000332	0.00368	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—GABRA2—conduct disorder	0.000328	0.00364	CbGpPWpGaD
Flunitrazepam—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000313	0.00347	CbGpPWpGaD
Flunitrazepam—UGT2B7—Biological oxidations—COMT—conduct disorder	0.000313	0.00347	CbGpPWpGaD
Flunitrazepam—UGT2B7—Biological oxidations—MAOA—conduct disorder	0.000311	0.00344	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metapathway biotransformation—COMT—conduct disorder	0.000309	0.00342	CbGpPWpGaD
Flunitrazepam—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000296	0.00328	CbGpPWpGaD
Flunitrazepam—CYP2A6—NRF2 pathway—SLC6A4—conduct disorder	0.000295	0.00327	CbGpPWpGaD
Flunitrazepam—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00029	0.00321	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—COMT—conduct disorder	0.000286	0.00316	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000284	0.00314	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—COMT—conduct disorder	0.000282	0.00312	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00028	0.0031	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—COMT—conduct disorder	0.000254	0.00282	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—MAOA—conduct disorder	0.000253	0.0028	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metapathway biotransformation—COMT—conduct disorder	0.000251	0.00278	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—COMT—conduct disorder	0.000251	0.00278	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00025	0.00277	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000249	0.00276	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000246	0.00273	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000244	0.00271	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000244	0.00271	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000242	0.00268	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000241	0.00267	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00024	0.00266	CbGpPWpGaD
Flunitrazepam—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000223	0.00248	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—COMT—conduct disorder	0.000219	0.00242	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—MAOA—conduct disorder	0.000217	0.00241	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—COMT—conduct disorder	0.000216	0.00239	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—MAOA—conduct disorder	0.000215	0.00238	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000214	0.00238	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000211	0.00233	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000206	0.00228	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000205	0.00227	CbGpPWpGaD
Flunitrazepam—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000204	0.00226	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000204	0.00226	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—COMT—conduct disorder	0.000196	0.00217	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—MAOA—conduct disorder	0.000195	0.00216	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—COMT—conduct disorder	0.000192	0.00213	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—MAOA—conduct disorder	0.000191	0.00211	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—COMT—conduct disorder	0.000189	0.00209	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—MAOA—conduct disorder	0.000187	0.00207	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—COMT—conduct disorder	0.000185	0.00205	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—MAOA—conduct disorder	0.000184	0.00204	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000176	0.00195	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000174	0.00193	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.000159	0.00176	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—COMT—conduct disorder	0.000158	0.00175	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—COMT—conduct disorder	0.000158	0.00175	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.000157	0.00174	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—MAOA—conduct disorder	0.000157	0.00174	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.000156	0.00173	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—COMT—conduct disorder	0.000155	0.00172	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—MAOA—conduct disorder	0.000154	0.0017	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—COMT—conduct disorder	0.000153	0.00169	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CGA—conduct disorder	0.000139	0.00154	CbGpPWpGaD
Flunitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000134	0.00149	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00012	0.00132	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.000119	0.00131	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CGA—conduct disorder	0.000119	0.00131	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.000118	0.00131	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000115	0.00127	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000115	0.00127	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—COMT—conduct disorder	0.000109	0.00121	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.000108	0.0012	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000108	0.00119	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.000108	0.00119	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000102	0.00113	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CGA—conduct disorder	9.64e-05	0.00107	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—COMT—conduct disorder	9.32e-05	0.00103	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	9.27e-05	0.00103	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—MAOA—conduct disorder	9.25e-05	0.00102	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	9.19e-05	0.00102	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	7.92e-05	0.000878	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CGA—conduct disorder	7.43e-05	0.000823	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—COMT—conduct disorder	7.19e-05	0.000796	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—MAOA—conduct disorder	7.14e-05	0.000791	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	7.09e-05	0.000785	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—COMT—conduct disorder	6.3e-05	0.000697	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—MAOA—conduct disorder	6.25e-05	0.000692	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CGA—conduct disorder	5.99e-05	0.000664	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CGA—conduct disorder	5.87e-05	0.00065	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—COMT—conduct disorder	5.35e-05	0.000593	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—MAOA—conduct disorder	5.32e-05	0.000589	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CGA—conduct disorder	4.53e-05	0.000502	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—COMT—conduct disorder	4.35e-05	0.000482	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—MAOA—conduct disorder	4.32e-05	0.000478	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CGA—conduct disorder	4.13e-05	0.000457	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CGA—conduct disorder	3.53e-05	0.000391	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—COMT—conduct disorder	3.35e-05	0.000371	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—MAOA—conduct disorder	3.33e-05	0.000369	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CGA—conduct disorder	2.72e-05	0.000302	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—COMT—conduct disorder	2.71e-05	0.0003	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—EP300—conduct disorder	2.7e-05	0.000299	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—MAOA—conduct disorder	2.69e-05	0.000298	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—COMT—conduct disorder	2.65e-05	0.000293	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—MAOA—conduct disorder	2.63e-05	0.000291	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—EP300—conduct disorder	2.3e-05	0.000254	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—COMT—conduct disorder	2.04e-05	0.000226	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—MAOA—conduct disorder	2.03e-05	0.000225	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.97e-05	0.000218	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—EP300—conduct disorder	1.87e-05	0.000207	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—COMT—conduct disorder	1.86e-05	0.000206	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—MAOA—conduct disorder	1.85e-05	0.000205	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.8e-05	0.000199	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—COMT—conduct disorder	1.59e-05	0.000176	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—MAOA—conduct disorder	1.58e-05	0.000175	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.53e-05	0.00017	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—EP300—conduct disorder	1.44e-05	0.000159	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—COMT—conduct disorder	1.23e-05	0.000136	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—MAOA—conduct disorder	1.22e-05	0.000135	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—EP300—conduct disorder	1.16e-05	0.000129	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—EP300—conduct disorder	1.14e-05	0.000126	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—EP300—conduct disorder	8.77e-06	9.71e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—EP300—conduct disorder	7.99e-06	8.85e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—EP300—conduct disorder	6.83e-06	7.57e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—EP300—conduct disorder	5.27e-06	5.84e-05	CbGpPWpGaD
